A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome

Abstract Background: The VCS technology of Beckman Coulter differentiates white blood cells based on measures of their volume, conductivity and light scatter. The current study investigated the predictive value of index measures, known as research population data, for the detection of chronic lymphatic leukemia and myelodysplastic syndrome. Methods: Blood cell counts were performed in samples from 44 patients with chronic lymphatic leukemia, 19 patients with myelodysplastic syndrome and 199 healthy blood donors using the Beckman Coulter LH750. Means and standard deviations of volume, conductivity and scatter of lymphocytes and neutrophils were evaluated as predictors for both diseases. Their specificity and selectivity were evaluated by logistic regression and receiver operating characteristic curve analysis. Results: Research population data were significantly different among groups. For chronic lymphatic leukemia, standard deviations of lymphocytes scatter and volume showed most relevant differences in comparison to healthy blood donors (sensitivity 88.6%, specificity 84.4%). For myelodysplastic syndrome, standard deviations of neutrophils conductivity were most predictive (sensitivity 73.7%, specificity 93.0%). Areas under corresponding receiver operating characteristic curves were 0.941 and 0.951, respectively. Conclusions: Based on their high predictive value, research population data could be routinely used to screen for chronic lymphatic leukemia and myelodysplastic syndrome. Clin Chem Lab Med 2008;46:85–8.

[1]  R. Collado,et al.  Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia. , 2007, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[2]  F. Chaves,et al.  Neutrophil volume distribution width: a new automated hematologic parameter for acute infection. , 2009, Archives of pathology & laboratory medicine.

[3]  R. Collado,et al.  Automated Neutrophil Morphology and Its Utility in the Assessment of Neutrophil Dysplasia and in the Diagnosis of Myelodysplastic Syndromes. , 2006 .

[4]  Ilse Aucamp,et al.  Development of an automated malaria discriminant factor using VCS technology. , 2006, American journal of clinical pathology.

[5]  J. Basuyau,et al.  Lymphocyte volume and conductivity indices of the haematology analyser Coulter GEN.S in lymphoproliferative disorders and viral diseases. , 2006, Clinical and laboratory haematology.

[6]  S. Marionneaux,et al.  The application of Beckman Coulter VCS technology at a major cancer center, with emphasis on the detection of circulating immature plasma cells in plasma cell leukemia. , 2006, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[7]  J. Bennett,et al.  The myelodysplastic syndromes: diagnosis and treatment. , 2006, Mayo Clinic proceedings.

[8]  P. Rubinstein,et al.  Analysis of 608 Umbilical Cord Blood (UCB) Transplants: HLA-Match Is a Critical Determinant of Transplant-Related Mortality (TRM) in the Post-Engraftment Period Even in the Absence of Acute Graft-vs-Host Disease (aGVHD). , 2005 .

[9]  Torsten Haferlach,et al.  Modern diagnostics in acute leukemias. , 2005, Critical reviews in oncology/hematology.

[10]  F. Chaves,et al.  Quantitative determination of neutrophil VCS parameters by the Coulter automated hematology analyzer: new and reliable indicators for acute bacterial infection. , 2005, American journal of clinical pathology.

[11]  Foster J. Provost,et al.  Confidence Bands for Roc Curves , 2004, ROCAI.

[12]  Sofus A. Macskassy,et al.  Confidence Bands for Roc Curves , 2003 .

[13]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[14]  M Cazzola,et al.  Myelodysplastic syndromes: recent advances. , 2001, Haematologica.